BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Regorafenib
1
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
8/10/2022 1:14:37 PM | Browse: 252 | Download: 561
2
Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness
4/15/2022 9:40:09 AM | Browse: 346 | Download: 684
3
Targeted agents for second-line treatment of advanced hepatocellular carcinoma
10/16/2019 12:17:24 PM | Browse: 671 | Download: 743
4
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma
8/7/2019 7:09:17 AM | Browse: 848 | Download: 1160
5
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
5/15/2018 7:28:22 AM | Browse: 1029 | Download: 1252
6
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 976 | Download: 1382
7
Last line therapy with sorafenib in colorectal cancer: A retrospective analysis
6/13/2016 9:14:00 AM | Browse: 1101 | Download: 1830
8
New active drugs for the treatment of advanced colorectal cancer
12/24/2015 8:55:00 AM | Browse: 883 | Download: 1405
9
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1086 | Download: 1461
10
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1081 | Download: 1186
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345